Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07577414 · ClinicalTrials.gov registry record · NA
Safety and Efficacy of Fetoscopic Endoluminal Tracheal Occlusion (FETO) in Congenital Diaphragmatic Hernia (CDH)
A NA study, sponsored by Dr Erin Perrone.
- Recruiting
- Registry status
- NA
- Development phase
- 40
- Enrollment target
NCT07577414 is a NA study that is actively recruiting participants, run by Dr Erin Perrone. The registered enrollment target is 40 participants.
The verdict
NCT07577414, a NA study, is actively recruiting participants, sponsored by Dr Erin Perrone.
- RECRUITING
- Registry status
- NA
- Development phase
- 40 participants
- Enrollment target
Study Summary
The purpose of the study is to determine if babies with left or right-sided CDH that undergo the FETO procedure survive more often and have fewer long-term complications than babies that have similar left or right-sided CDH that elect not to have the FETO procedure performed during pregnancy.
Interventions
- DEVICE FETO with Goldballoon Detachable Balloon (GOLDBAL2) along with the Delivery Microcatheter (BALTACCI-BDPE100)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2026-06-17 |
| Est. Completion | 2038-04 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07577414
The ClinicalTrials.gov registry entry for NCT07577414 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Dr Erin Perrone, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which FETO with Goldballoon Detachable Balloon (GOLDBAL2) along with the Delivery Microcatheter (BALTACCI-BDPE100) is the first listed.
NCT07577414 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07577414 about?
NCT07577414 is a clinical study titled "Safety and Efficacy of Fetoscopic Endoluminal Tracheal Occlusion (FETO) in Congenital Diaphragmatic Hernia (CDH)". The purpose of the study is to determine if babies with left or right-sided CDH that undergo the FETO procedure survive more often and have fewer long-term complications than babies that have similar left or right-sided CDH that elect not to have the FETO procedure performed during pregnancy.
What is the current status of trial NCT07577414?
This trial is currently recruiting. It is a NA study. The enrollment target is 40 participants. The study started on 2026-06-17. Estimated completion is 2038-04.
What interventions are being tested in trial NCT07577414?
The interventions under investigation include: FETO with Goldballoon Detachable Balloon (GOLDBAL2) along with the Delivery Microcatheter (BALTACCI-BDPE100) (DEVICE).
Who is sponsoring clinical trial NCT07577414?
This trial is sponsored by Dr Erin Perrone, which has 2 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.